美国商业保险患者中鼻息肉复发相关的经济负担
本研究为回顾性匹配队列研究,基于Optum Clinformatics Data Mart数据库(2014年10月1日至2019年12月31日),比较内镜下鼻窦手术后鼻息肉复发与未复发患者的医疗资源利用和费用。复发组在索引后12个月的门诊和急诊就诊次数分别增加36%和51%,平均医疗费用高出9676美元(24039美元 vs 14363美元,P < .01)。结论认为鼻息肉复发与显著经济负担相关,主要由门诊服务驱动。
要点
- 复发组索引后12个月门诊就诊次数增加36%,急诊就诊次数增加51%(均P < .01)。
- 复发组平均医疗费用为24039美元,比非复发组(14363美元)高9676美元(P < .01)。
- 费用差异主要由门诊费用驱动:复发组额外门诊费用8211美元,额外鼻息肉相关门诊费用6062美元(均P < .01)。
核心结论
- 鼻息肉复发与显著经济负担相关,该负担似乎由门诊服务驱动。
研究设计与样本
- 回顾性匹配队列研究,使用Optum Clinformatics Data Mart数据库(2014年10月1日至2019年12月31日)。
- 纳入初次内镜下鼻窦手术或新诊断鼻息肉后行鼻息肉切除术的商业保险成人患者。
- 复发队列通过基于索赔的算法识别,非复发队列随机选取索引日期,两队列按索引前12个月基线特征以倾向评分和精确匹配因素1:1匹配。
- 匹配后每队列各1574例患者(中位年龄54岁,40%女性),基线医疗费用相似(复发组34420美元,非复发组33737美元)。
主要发现
- 16693例初次内镜下鼻窦手术患者中识别出3343例鼻息肉复发。
- 索引后12个月,复发组门诊就诊次数增加36%,急诊就诊次数增加51%(均P < .01)。
- 复发组平均医疗费用为24039美元,非复发组为14363美元,差异9676美元(P < .01)。
- 费用差异由复发组额外门诊费用8211美元和额外鼻息肉相关门诊费用6062美元驱动(均P < .01)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare health care resource utilization (HRU) and costs among commercially insured patients with nasal polyposis (NP) with and without recurrence after endoscopic sinus surgery (ESS). STUDY DESIGN: Retrospective matched cohort study. SETTING: Adults with initial ESS or an NP excision after a new NP diagnosis were identified in Optum's Clinformatics Data Mart Database (October 1, 2014-December 31, 2019). METHODS: The index date was the date of NP recurrence, identified with a claims-based algorithm for the recurrent cohort, or a random date for the nonrecurrent cohort. Patients in both cohorts were matched 1:1 on baseline characteristics (12 months preindex) via propensity scores and exact matching factors. Annual HRU and costs (2019 US$) were compared between the matched cohorts at 12 months postindex. RESULTS: NP recurrence was identified among 3343 of 16,693 patients with initial ESS; after matching, each cohort comprised 1574 patients (median age, 54 years; 40% female) with similar baseline health care costs (recurrent, $34,420; nonrecurrent, $33,737). At 12 months postindex, the recurrent cohort had higher HRU, including 36% and 51% more outpatient and emergency department visits, respectively (all P < .01). Mean health care costs were $9676 higher in the recurrent cohort ($24,039) relative to the nonrecurrent cohort ($14,363, P < .01). The mean cost difference between cohorts was driven by $8211 in additional outpatient costs, as well as $6062 in additional NP-related outpatient costs, in the recurrent cohort (all P < .01). CONCLUSION: NP recurrence is associated with a substantial economic burden, which appears to be driven by outpatient services.
引用
- Zhdanava M, Ndife B, Pilon D, et al. Economic Burden Associated With Nasal Polyposis Recurrence Among Commercially Insured Patients in the United States. Otolaryngol Head Neck Surg. 2023. PMID: 35349388. doi:10.1177/01945998221089187
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。